Phase 3 clinical trial designed to evaluate the safety and efficacy of tivozanib in combination with nivolumab
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer
New Phase II data show vast majority of patients experiencing no relapses or disability progression
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
Phase 3 study results will form the basis for future discussions with global regulatory authorities
Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG)
The approval further adds to Biocon’s portfolio of complex drug products
Subscribe To Our Newsletter & Stay Updated
